Industry News
Oncology start-up Senz gets seed funding for chemo agent
Start-up Senz Oncology has secured seed funding to support the development of a chemotherapeutic agent as a potential treatment for acute leukaemias. [ + ]
CSL lifts FY12 profit to US$1 billion
CSL (ASX:CSL) grew its FY12 net profit 4.5% to $983 million, despite taking a significant hit on exchange rates. [ + ]
Researchers develop DNA sequencing tests for hereditary diseases
Scientists at the University of Medicine and Dentistry of New Jersey-New Jersey Medical School (UMDNJ-NJMS) have developed DNA sequencing tests that hold significant promise for decreasing costs associated with diagnosing cancer and hereditary diseases, including cystic fibrosis. [ + ]
Advances in decades-old dream of mining seawater for uranium
Scientists have reported progress towards a 40-year-old dream of extracting uranium for nuclear power from seawater, which holds at least four billion tonnes of the precious material. [ + ]
Call to boycott killer robots
Engineers should stop working on killer robots and kick the habit of military funding, a leading Australian applied ethicist has said. [ + ]
Novasys appointed Isocolor distributor
Novasys has recently been appointed sole and exclusive distributor for Australia for the Isocolor range of colour quality control and colour formulation software products. [ + ]
Science in the blood: L’Oreal Fellowship awarded to WEHI’s Kylie Mason
One of the three L’Oreal Fellowships has been awarded to Dr Kylie Mason for her work understanding the relationship between cancer and blood. [ + ]
BioDiem viral vector research clears first hurdle
BioDiem (ASX:BDM) and French partner VIVALIS have reached two significant milestones in their work towards the development of a new viral vector. [ + ]
PM’s Manufacturing Taskforce reports
Non-government members of the Prime Minister's Manufacturing Taskforce, representing business, unions and the research sector, have released their report Smarter Manufacturing for a Smarter Australia, after the group was established in late 2011. [ + ]
Bioniche launching more animal health products
Bioniche (ASX:BNC) has launched an equine inflammation treatment in the US, and scored Canadian distribution rights for six more products. [ + ]
Sartorius loses distribution rights to the Biohit Ergo Tube
Having paid €68m for Biohit’s liquid handling business, Sartorius has failed to reach an agreement with the patent holders and manufacturers of the Biohit Ergo Tube. [ + ]
Scientists’ gold discovery sheds light on catalysis
A physicist at the University of York has played a key role in international research which has made an important advance in establishing the catalytic properties of gold at a nano level. [ + ]
QRxPharma meets with FDA about MoxDuo IR knockback
QRxPharma (ASX:QRX) executives left a pivotal meeting with the US FDA hopeful of being able to avoid prolonging the MoxDuo IR approvals process with another clinical trial. [ + ]
Molecular code cracked: potential for future treatments of genetic disease
Scientists have cracked a code underlying recognition of RNA molecules by a superfamily of RNA-binding proteins called pentatricopeptide repeat (PPR) proteins. This may open the way to destroying or correcting defective gene products, such as those that cause genetic disorders in humans. [ + ]
Science leader joins NZ Ministry for Primary Industries
Dr Ian Ferguson (MNZM) has been appointed to the newly created position of Departmental Science Adviser for the Ministry for Primary Industries (MPI), Deputy Director General of Policy Paul Stocks announced today. [ + ]
